Literature DB >> 8574838

Selective increases in antibody isotypes and immunoglobulin G subclass responses to secreted antigens in tuberculosis patients and healthy household contacts of the patients.

R Hussain1, G Dawood, N Abrar, Z Toossi, A Minai, M Dojki, J J Ellner.   

Abstract

Mycobacterium tuberculosis-specific antibodies (immunoglobulin M [IgM], IgE, IgG, and IgG subclasses) were determined in 164 tuberculosis patients (pulmonary involvement, n = 135; lymph node involvement, n = 29), 59 healthy household contacts (HC), and 51 healthy endemic donors (EC) by a quantitative enzyme-linked immunosorbent assay for reactivity with culture filtrate. Among the isotypes, significant differences between tuberculosis patient groups with either pulmonary or lymph node involvement and healthy control groups (HC and EC) were detected only for IgG (P < 0.001) and IgG1 (P < 0.001) antibodies. Pulmonary patients also showed a significant difference with IgM (P < 0.01) and IgE (P < 0.05) antibodies. HC showed elevation of only IgM antibodies compared with EC, indicating that IgM antibodies may be an indicator of recent infection with M. tuberculosis. These results suggest that the switching of IgM antibody response to IgG1 is a critical event in disease progression. Polyclonal IgG1, IgG3, and IgE antibodies also showed significant elevation (P < 0.05) in patients compared with EC. A strong correlation (rho = 0.254; P < 0.003) was observed between M. tuberculosis-specific IgG1 and polyclonal IgG1 in patients, suggesting that activations of antigen-specific and polyclonal antibodies are related events. No correlation was found between IgG1 antibodies and purified protein derivative skin test results. Since IgG1 antibody responses to culture filtrate are present only after disease establishment, IgG1 responses could provide a useful diagnostic marker of disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8574838      PMCID: PMC170229          DOI: 10.1128/cdli.2.6.726-732.1995

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  31 in total

1.  Suppressor adherent cells in human tuberculosis.

Authors:  J J Ellner
Journal:  J Immunol       Date:  1978-12       Impact factor: 5.422

2.  Direct stimulation of monocyte release of interleukin 1 by mycobacterial protein antigens.

Authors:  R S Wallis; H Fujiwara; J J Ellner
Journal:  J Immunol       Date:  1986-01       Impact factor: 5.422

3.  Analysis of T cell subsets by monoclonal antibodies in patients with tuberculosis after in vitro stimulation with purified protein derivative of tuberculin.

Authors:  H Shiratsuchi; I Tsuyuguchi
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

Review 4.  The humoral immune response in tuberculosis: its nature, biological role and diagnostic usefulness.

Authors:  J M Grange
Journal:  Adv Tuberc Res       Date:  1984

5.  The quantitation of parasite-specific human IgG and IgE in sera: evaluation of solid-phase RIA and ELISA methodology.

Authors:  R G Hamilton; R Hussain; E A Ottesen; N F Adkinson
Journal:  J Immunol Methods       Date:  1981       Impact factor: 2.303

6.  Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins.

Authors:  T R Mosmann; H Cherwinski; M W Bond; M A Giedlin; R L Coffman
Journal:  J Immunol       Date:  1986-04-01       Impact factor: 5.422

7.  Immunoglobulin G1 (IgG1) and IgG3 antibodies are markers of progressive disease in leprosy.

Authors:  R Hussain; A Kifayet; T J Chiang
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

8.  IgG2 subclass restriction of antibody to pneumococcal polysaccharides.

Authors:  D J Barrett; E M Ayoub
Journal:  Clin Exp Immunol       Date:  1986-01       Impact factor: 4.330

9.  The spectrum of human tuberculosis.

Authors:  L Lenzini; P Rottoli; L Rottoli
Journal:  Clin Exp Immunol       Date:  1977-02       Impact factor: 4.330

10.  Studies on human antibodies. VI. Selective variations in subgroup composition and genetic markers.

Authors:  W J Yount; M M Dorner; H G Kunkel; E A Kabat
Journal:  J Exp Med       Date:  1968-03-01       Impact factor: 14.307

View more
  32 in total

1.  Opsonizing antibodies (IgG1) up-regulate monocyte proinflammatory cytokines tumour necrosis factor-alpha (TNF-alpha) and IL-6 but not anti-inflammatory cytokine IL-10 in mycobacterial antigen-stimulated monocytes-implications for pathogenesis.

Authors:  R Hussain; H Shiratsuchi; M Phillips; J Ellner; R S Wallis
Journal:  Clin Exp Immunol       Date:  2001-02       Impact factor: 4.330

2.  Combining Monophosphoryl Lipid A (MPL), CpG Oligodeoxynucleotide (ODN), and QS-21 Adjuvants Induces Strong and Persistent Functional Antibodies and T Cell Responses against Cell-Traversal Protein for Ookinetes and Sporozoites (CelTOS) of Plasmodium falciparum in BALB/c Mice.

Authors:  Sakineh Pirahmadi; Sedigheh Zakeri; Akram A Mehrizi; Navid D Djadid; Abbas-Ali Raz; Jafar J Sani
Journal:  Infect Immun       Date:  2019-05-21       Impact factor: 3.441

3.  Serological investigation of IgG levels and subclasses in rheumatoid arthritis patients following ingestion of bovine type II collagen: results of a double blind, randomised controlled trial.

Authors:  Amir Farboud; Ernest Choy
Journal:  Clin Rheumatol       Date:  2010-05-04       Impact factor: 2.980

4.  Recombinant IgG2a Fc (M045) multimers effectively suppress experimental autoimmune myasthenia gravis.

Authors:  Muthusamy Thiruppathi; Jian Rong Sheng; Liangcheng Li; Bellur S Prabhakar; Matthew N Meriggioli
Journal:  J Autoimmun       Date:  2014-01-02       Impact factor: 7.094

5.  Reduced immunogenicity of Plasmodium falciparum gamete surface antigen (Pfs48/45) in mice after disruption of disulphide bonds - evaluating effect of interferon-γ-inducible lysosomal thiol reductase.

Authors:  Kristen M Merino; Geetha P Bansal; Nirbhay Kumar
Journal:  Immunology       Date:  2016-06-29       Impact factor: 7.397

6.  Influence of pathological progression on the balance between cellular and humoral immune responses in bovine tuberculosis.

Authors:  Michael D Welsh; Rodat T Cunningham; David M Corbett; R Martyn Girvin; James McNair; Robin A Skuce; David G Bryson; John M Pollock
Journal:  Immunology       Date:  2005-01       Impact factor: 7.397

7.  PPD-specific IgG1 antibody subclass upregulate tumour necrosis factor expression in PPD-stimulated monocytes: possible link with disease pathogenesis in tuberculosis.

Authors:  R Hussain; H Shiratsuchi; J J Ellner; R S Wallis
Journal:  Clin Exp Immunol       Date:  2000-03       Impact factor: 4.330

8.  IgG1 antimycobacterial antibodies can reverse the inhibitory effect of pentoxifylline on tumour necrosis factor alpha (TNF-alpha) secreted by mycobacterial antigen-stimulated adherent cells.

Authors:  S M Thakurdas; Z Hasan; R Hussain
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

9.  Monocytes and neutrophils from tuberculosis patients are insensitive to anti-inflammatory effects triggered by the prototypic formyl peptide N-formyl-methionyl-leucyl-phenylalanine (FMLP).

Authors:  M Beigier-Bompadre; M Alemán; P Barrionuevo; M C Franco; C J Rubel; M Del C Sasiain; M S Palermo; E Abbate; M A Isturiz
Journal:  Clin Exp Immunol       Date:  2003-08       Impact factor: 4.330

10.  Critical role for mouse marginal zone B cells in PF4/heparin antibody production.

Authors:  Yongwei Zheng; Mei Yu; Andrew Podd; Liudi Yuan; Debra K Newman; Renren Wen; Gowthami Arepally; Demin Wang
Journal:  Blood       Date:  2013-03-04       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.